Xeljanz xr and Hypoacusis - a phase IV clinical study of FDA data
Summary:
Hypoacusis is found among people who take Xeljanz xr, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Xeljanz xr and have Hypoacusis. It is created by eHealthMe based on reports of 82,316 people who have side effects when taking Xeljanz xr from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
82,316 people reported to have side effects when taking Xeljanz xr.
Among them, 1,119 people (1.36%) have Hypoacusis.
What is Xeljanz xr?
Xeljanz xr has active ingredients of tofacitinib citrate. eHealthMe is studying from 82,349 Xeljanz xr users for its effectiveness, alternative drugs and more.
What is Hypoacusis?
Hypoacusis (loss of hearing) is found to be associated with 1,848 drugs and 1,133 conditions by eHealthMe.
Number of Xeljanz xr and Hypoacusis reports submitted per year:
Time on Xeljanz xr when people have Hypoacusis *:
Gender of people who have Hypoacusis when taking Xeljanz xr*:
Age of people who have Hypoacusis when taking Xeljanz xr *:
Common drugs people take besides Xeljanz xr *:
Common side effects people have besides Hypoacusis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Xeljanz xr and have Hypoacusis?
Check whether Hypoacusis is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Hypoacusis and when was it recovered:
Expand to all the drugs that have ingredients of tofacitinib citrate:
Alternative drugs to, pros and cons of Xeljanz xr:
- Xeljanz xr (82,349 reports)
Common Xeljanz xr side effects:
- Drug ineffective: 12,547 reports
- Pain: 9,741 reports
- Joint pain: 6,290 reports
- Headache (pain in head): 4,768 reports
- Fatigue (feeling of tiredness): 4,439 reports
- Malaise (a feeling of general discomfort or uneasiness): 4,414 reports
- Diarrhea: 3,006 reports
Browse all side effects of Xeljanz xr:
a b c d e f g h i j k l m n o p q r s t u v w x y zHypoacusis treatments and more:
- Hypoacusis (38,153 reports)
COVID vaccines that are related to Hypoacusis:
- Hypoacusis in Moderna COVID Vaccine
- Hypoacusis in Pfizer BioNTech Covid Vaccine
- Hypoacusis in Johnson and Johnson Covid Vaccine
Common drugs associated with Hypoacusis:
- Lyrica: 2,181 reports
- Xeljanz: 2,003 reports
- Entresto: 1,843 reports
- Aspirin: 1,729 reports
- Prednisone: 1,459 reports
- Enbrel: 1,454 reports
- Lantus: 1,186 reports
- Xeljanz xr: 1,119 reports
- Humalog: 1,095 reports
- Revlimid: 1,016 reports
All the drugs that are associated with Hypoacusis:
- Hypoacusis (1,848 drugs)
Common conditions associated with Hypoacusis:
- Rheumatoid arthritis: 2,304 reports
- Multiple sclerosis: 1,776 reports
- High blood pressure: 1,403 reports
- Type 2 diabetes: 1,369 reports
- Multiple myeloma: 1,184 reports
- Diabetes: 1,156 reports
- High blood cholesterol: 1,119 reports
All the conditions that are associated with Hypoacusis:
- Hypoacusis (1,133 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tofacitinib citrate (the active ingredients of Xeljanz xr) and Xeljanz xr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- The Flu and drugs of ingredients of folic acid - 4 seconds ago
- Provigil and Constipation - 6 seconds ago
- Lisinopril And Hydrochlorothiazide vs. Coreg Cr - 10 seconds ago
- Luvox and Pulmonary Artery Stenosis Congenital - 10 seconds ago
- Baclofen and Cyclic Vomiting Syndrome - 12 seconds ago
- Zovia 1/35E-21 vs. Cyclafem 1/35 - 16 seconds ago
- Trelstar and Bronchitis - 18 seconds ago
- Fenofibrate and Herpes Zoster - 21 seconds ago
- Betaderm and Irbesartan drug interaction - 23 seconds ago
- Memantine and Appetite - Decreased - 24 seconds ago